Ki-67: A prognostic factor for low-grade glioma?

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 4, 2002, Pages 996-1001

  Fisher, Barbara J ^a,b   Naumova, Elitza ^a   Leighton, Christopher C ^a   Naumov, George N ^a   Kerklviet, Nancy ^a   Fortin, David ^a,b   Macdonald, David R ^a,b   Cairncross, J Gregory ^a,b   Bauman, Glenn S ^a   Stitt, Larry ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

Ki 67; Low grade glioma; Proliferation markers; Radiotherapy

Indexed keywords

COMPUTER AIDED ANALYSIS; DOSIMETRY; PATIENT MONITORING; PEDIATRICS; RADIOTHERAPY; SURGERY;

NUCLEAR PROLIFERATION MARKER;

TUMORS;

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CHILD; FEMALE; GLIOMA; HUMANS; KI-67 ANTIGEN; MALE; PROGNOSIS;

EID: 18344380809     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02720-1     Document Type: Article

References (30)

1. Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis
2. Improving diagnostic accuracy and interobserver concordance in classification and grading of primary gliomas
3. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials
4. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
5. Relationship between Ki-67 positive labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
6. Determination of proliferation activities in human brain tumor specimens: A comparison of methods
7. The monoclonal antibody Ki-67 as a marker for proliferating cells in sterotactic biopsies of brain tumours
8. Identification of proliferating cells in human gliomas using the monoclonal Ki-67
9. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: A Ki-67 study
10. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms
11. Prognostic implications of p53 protein, epidermal growth factor receptor and Ki-67 labeling in brain tumours
12. Relationships between Ki-67 labeling index, amplication of the epidermal growth factor receptor gene, and prognosis in human glioblastomas
13. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas
14. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki-67 in benign and malignant peripheral nerve sheath tumours
15. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value
16. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters
17. Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiotherapy
18. Antigen unmasking on formalin-fixed paraffin-embedded tissues using microwaves: A review
19. Interpretation of some results of radiotherapy and an attempt at determining a logical technique of treatment
20. Differential response of rapidly and slowly proliferating human cells to X-irradiation
21. Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression
22. The proliferative potential of the pilocytic astrocytoma: The relation between MIB-1 labeling and clinical and neuro-radiological follow-up
23. Prognostic significance of Ki-67 labeling indices obtained using monoclonal antibody in patients with supratentorial astrocytomas
24. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy
25. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults
26. Cell proliferation in serial biopsies through human malignant brain tumours: Measurement using Ki-67 antibody labeling
27. Analysis of proliferation and apoptosis in brain gliomas: Prognostic and clinical value
28. Proliferative activity and prognosis of low-grade astrocytomas
29. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas
30. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy